Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice

Abstract Mycobacterium avium subspecies paratuberculosis (MAP) causes chronic progressive granulomatous enteritis leading to diarrhoea, weight loss, and eventual death in ruminants. Commercially available vaccines provide only partial protection against MAP infection and can compromise the use of bo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sandeep K. Gupta, Natalie A. Parlane, Dongwen Luo, Bernd H. A. Rehm, Axel Heiser, Bryce M. Buddle, D. Neil Wedlock
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/81a42884569a48c8bc3f1e3aff5f5f43
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:81a42884569a48c8bc3f1e3aff5f5f43
record_format dspace
spelling oai:doaj.org-article:81a42884569a48c8bc3f1e3aff5f5f432021-12-02T11:57:56ZSelf-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice10.1038/s41598-020-79407-72045-2322https://doaj.org/article/81a42884569a48c8bc3f1e3aff5f5f432020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79407-7https://doaj.org/toc/2045-2322Abstract Mycobacterium avium subspecies paratuberculosis (MAP) causes chronic progressive granulomatous enteritis leading to diarrhoea, weight loss, and eventual death in ruminants. Commercially available vaccines provide only partial protection against MAP infection and can compromise the use of bovine tuberculosis diagnostic tests. Here, we report the development of a protein-particle-based vaccine containing MAP antigens Ag85A202–347-SOD1–72-Ag85B173–330-74F1–148+669–786 as a fusion (‘MAP fusion protein particle’). The fusion antigen displayed on protein particles was identified using mass spectrometry. Surface exposure and accessibility of the fusion antigen was confirmed by flow cytometry and ELISA. The MAP fusion protein particle vaccine induced strong antigen-specific T-cell immune responses in mice, as indicated by increased cytokine (IFN-γ and IL-17A) and costimulatory signals (CD40 and CD86) in these animals. Following MAP-challenge, a significant reduction in bacterial burden was observed in multiple organs of the mice vaccinated with the MAP fusion protein particle vaccine compared with the PBS group. The reduction in severity of MAP infection conferred by the MAP fusion protein particle vaccine was similar to that of Silirum and recombinant protein vaccines. Overall, the results provide evidence that MAP antigens can be engineered as a protein particulate vaccine capable of inducing immunity against MAP infection. This utility offers an attractive platform for production of low-cost particulate vaccines against other intracellular pathogens.Sandeep K. GuptaNatalie A. ParlaneDongwen LuoBernd H. A. RehmAxel HeiserBryce M. BuddleD. Neil WedlockNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sandeep K. Gupta
Natalie A. Parlane
Dongwen Luo
Bernd H. A. Rehm
Axel Heiser
Bryce M. Buddle
D. Neil Wedlock
Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice
description Abstract Mycobacterium avium subspecies paratuberculosis (MAP) causes chronic progressive granulomatous enteritis leading to diarrhoea, weight loss, and eventual death in ruminants. Commercially available vaccines provide only partial protection against MAP infection and can compromise the use of bovine tuberculosis diagnostic tests. Here, we report the development of a protein-particle-based vaccine containing MAP antigens Ag85A202–347-SOD1–72-Ag85B173–330-74F1–148+669–786 as a fusion (‘MAP fusion protein particle’). The fusion antigen displayed on protein particles was identified using mass spectrometry. Surface exposure and accessibility of the fusion antigen was confirmed by flow cytometry and ELISA. The MAP fusion protein particle vaccine induced strong antigen-specific T-cell immune responses in mice, as indicated by increased cytokine (IFN-γ and IL-17A) and costimulatory signals (CD40 and CD86) in these animals. Following MAP-challenge, a significant reduction in bacterial burden was observed in multiple organs of the mice vaccinated with the MAP fusion protein particle vaccine compared with the PBS group. The reduction in severity of MAP infection conferred by the MAP fusion protein particle vaccine was similar to that of Silirum and recombinant protein vaccines. Overall, the results provide evidence that MAP antigens can be engineered as a protein particulate vaccine capable of inducing immunity against MAP infection. This utility offers an attractive platform for production of low-cost particulate vaccines against other intracellular pathogens.
format article
author Sandeep K. Gupta
Natalie A. Parlane
Dongwen Luo
Bernd H. A. Rehm
Axel Heiser
Bryce M. Buddle
D. Neil Wedlock
author_facet Sandeep K. Gupta
Natalie A. Parlane
Dongwen Luo
Bernd H. A. Rehm
Axel Heiser
Bryce M. Buddle
D. Neil Wedlock
author_sort Sandeep K. Gupta
title Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice
title_short Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice
title_full Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice
title_fullStr Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice
title_full_unstemmed Self-assembled particulate vaccine elicits strong immune responses and reduces Mycobacterium avium subsp. paratuberculosis infection in mice
title_sort self-assembled particulate vaccine elicits strong immune responses and reduces mycobacterium avium subsp. paratuberculosis infection in mice
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/81a42884569a48c8bc3f1e3aff5f5f43
work_keys_str_mv AT sandeepkgupta selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
AT natalieaparlane selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
AT dongwenluo selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
AT berndharehm selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
AT axelheiser selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
AT brycembuddle selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
AT dneilwedlock selfassembledparticulatevaccineelicitsstrongimmuneresponsesandreducesmycobacteriumaviumsubspparatuberculosisinfectioninmice
_version_ 1718394817636990976